104 related articles for article (PubMed ID: 10446693)
1. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
Gürel S; Dolar E; Yerci O; Samli B; Oztürk H; Nak SG; Gülten M; Memik F
J Int Med Res; 1999; 27(2):74-8. PubMed ID: 10446693
[TBL] [Abstract][Full Text] [Related]
2. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein and prognosis in gastric carcinoma.
Gürel S; Dolar E; Yerci O; Samli B; Oztürk H; Nak SG; Gülten M; Memik F
J Int Med Res; 1999; 27(2):85-9. PubMed ID: 10446695
[TBL] [Abstract][Full Text] [Related]
4. Investigation of ErbB-2 overexpression on patients with gastric cancer in Eastern Anatolia of Turkey.
Emre H; Tekin SB; Doğan H; Çayır K; Bilici M; Sipal S; Pirim I
Turk J Gastroenterol; 2013; 24(3):211-7. PubMed ID: 24226713
[TBL] [Abstract][Full Text] [Related]
5. c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.
Pinto-de-Sousa J; David L; Almeida R; Leitão D; Preto JR; Seixas M; Pimenta A
Int J Surg Pathol; 2002 Oct; 10(4):247-56. PubMed ID: 12490974
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis.
Tantawy A; Youins L; Hamza M
Eur Arch Otorhinolaryngol; 1999; 256(2):72-7. PubMed ID: 10068894
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
Tsugawa K; Yonemura Y; Hirono Y; Fushida S; Kaji M; Miwa K; Miyazaki I; Yamamoto H
Oncology; 1998; 55(5):475-81. PubMed ID: 9732228
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.
Dursun A; Poyraz A; Celik B; Akyol G
Pathol Oncol Res; 1999; 5(2):104-6. PubMed ID: 10393360
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
Kim JP; Oh ST; Hwang TS; Chi JG
J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
[TBL] [Abstract][Full Text] [Related]
13. Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients.
Satiroglu-Tufan NL; Bir F; Calli-Demirkan N
World J Gastroenterol; 2006 May; 12(20):3283-7. PubMed ID: 16718853
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?
Ohguri T; Sato Y; Koizumi W; Saigenji K; Kameya T
Int J Cancer; 1993 Jan; 53(1):75-9. PubMed ID: 8093216
[TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
Doventas A; Bilici A; Demirell F; Ersoy G; Turna H; Doventas Y
Hepatogastroenterology; 2012 Oct; 59(119):2196-201. PubMed ID: 23435135
[TBL] [Abstract][Full Text] [Related]
17. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
Ooi A; Kobayashi M; Mai M; Nakanishi I
Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis.
Oshima CT; Lanzoni VP; Iriya K; Forones NM
Int J Biol Markers; 2001; 16(4):250-4. PubMed ID: 11820720
[TBL] [Abstract][Full Text] [Related]
19. Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach.
Honda T; Tamura G; Endoh Y; Nishizuka S; Kawata S; Motoyama T
Jpn J Clin Oncol; 2005 Oct; 35(10):580-6. PubMed ID: 16254038
[TBL] [Abstract][Full Text] [Related]
20. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
